Acurx Pharmaceuticals, Inc.
ACXP • NASDAQ
Acurx Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO David Luci, with a market cap of $10.7M.
Market Cap$10.7M
Employees4.0
CEODavid Luci
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 12, 2026 · in a monthQ1 2026
Financials
ACX
Acurx Pharmaceuticals, Inc. FAQ
Common questions about Acurx Pharmaceuticals, Inc.
Acurx Pharmaceuticals, Inc. is scheduled to report earnings for Q1 2026 on May 12, 2026.
Acurx Pharmaceuticals, Inc. has approximately 4 employees.